Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Phase 3
Recruiting
- Conditions
- Myasthaenia Gravis
- Interventions
- Drug: efgartigimod administration
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 30
- Registration Number
- NCT06765161
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2
Completed
- Conditions
- Glioblastoma Multiforme of Brain
- Interventions
- Biological: avelumab
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 30
- Registration Number
- NCT03047473
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Other: multimodal evoked potentials
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 14
- Registration Number
- NCT03047460
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 10
- Registration Number
- NCT02623946
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 46
- Registration Number
- NCT02383550
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients
Phase 4
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 44
- Registration Number
- NCT02146534
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2012-08-07
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Clinique Neuro-Outaouais
- Target Recruit Count
- 63
- Registration Number
- NCT01658384
- Locations
- π¨π¦
Clinique Neuro-Outaouais, Gatineau, Quebec, Canada
Β© Copyright 2025. All Rights Reserved by MedPath